The Quality of Life in Patients with Ulcerative Colitis and Concomitant Subclinical Atherosclerosis

I.V. Chopei, T.M. Ternushchak, S.S. Filip


The objective of this study was to evaluate the quality of life in patients with ulcerative colitis (UC) of moderate severity and concomitant subclinical atherosclerosis before and after combination treatment with statin and omega-3 polyunsaturated fatty acids (PUFAs).
In patients with UC and concomitant atherosclerosis we have detected deterioration in quality of life mostly by the components of physical health (SF-36 questionnaire), which is directly proportional to the degree of atherosclerosis severity (p < 0.05). During combined treatment with statins and omega-3 PUFAs, there was a significant improvement in parameters of not only physical, but also mental health (p < 0.05). Analyzing data by specialized GSRS questionnaires, we have noted improvement in quality of life by three of the five scales — abdominal pain, dyspeptic and diarrheal syndromes (p < 0.05).


ulcerative colitis; subclinical atherosclerosis; quality of life; statins; omega-3 polyunsaturated fatty acids


Руководство по исследованию качества жизни в медицине / Под ред. Ю.Л. Шевченко. — СПб.: ОЛМА Медиа Груп, 2007. — 315 с.

Бойко Т.Й. Якість життя хворих на хронічні запальні захворювання кишечнику в динаміці лікування / Т.Й. Бойко, Т.М. Толстикова, М.В Стойкевич // Сучасна гастроентерологія. — 2011. — № 5(61). — С. 36-40.

Хіміон Л.В. Переваги та перспективи широкого використання статинів у загальнолікарській практиці / Л.В. Хіміон // Мистецтво лікування. — 2011. — № 2(78). — С. 38-46.

ACCF/AHA 2013 Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines / D.C. Goff, D.M. Lloyd-Jones Jr, Glen Bennett [et al.] // Circulation. — 2013. — 51 p.

Bernklev T. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms / T. Bernklev, J. Jahnsen, I. Lygren [et al.] // Inflamm. Bowel Dis. — 2005. — Vol. 11. — P. 909-918.

Bernstein C.N. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010 / C.N. Bernstein, M. Fried [et al.] // Inflamm. Bowel Dis. — 2011. — Vol. 16(1). — P. 112-124.

Garolla A. Reduced endothelial progenitor cell number and function in inflammatory bowel disease: a possible link to the pathogenesis / A. Garolla, R. D’Incà, D. Checchin // Am. J. Gastroenterol. — 2009. — Vol. 104. — P. 2500-2507.

Irvine E.J. Quality of life of patients with ulcerative colitis: past, present, and future / E.J. Irvine // Inflamm. Bowel Dis. — 2008. — Vol. 14(4). — P. 554-565.

Kocaman O. Endothelial dysfunction in patients with ulcerative colitis / O. Kocaman, T. Sahin, C. Aygun [et al.] // Inflamm. Bowel Dis. — 2006. — Vol. 12(3). — P. 166-171.

Nedelciuc O. Quality of life in patients with ulcerative colitis / O. Nedelciuc, I. Pintilie, M. Dranga // Rev. Med. Chir. Soc. Med. Nat. Iasi. — 2012. — Vol. 116(3). — P. 756-760.

Reinisch W. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis / W. Reinisch, W.J. Sandborn, M. Bala [et al.] // Inflamm. Bowel Dis. — 2007. — Vol. 13. — P. 1135-1140.

Talking about life and IBD: A paradigm for improving patient-physician communication / R. Mitchell, A. Kremer, N. Westwood [et al.] // GCC. — 2009. — № 3. — P. 1-3.

Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019


   Seo анализ сайта